Gamal Sidra

1.1k total citations
3 papers, 17 citations indexed

About

Gamal Sidra is a scholar working on Hematology, Oncology and Dermatology. According to data from OpenAlex, Gamal Sidra has authored 3 papers receiving a total of 17 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hematology, 2 papers in Oncology and 1 paper in Dermatology. Recurrent topics in Gamal Sidra's work include Cancer Treatment and Pharmacology (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Platelet Disorders and Treatments (1 paper). Gamal Sidra is often cited by papers focused on Cancer Treatment and Pharmacology (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Platelet Disorders and Treatments (1 paper). Gamal Sidra collaborates with scholars based in United Kingdom. Gamal Sidra's co-authors include Nigel H. Russell, Geoff Lucas, Edwin Massey, Ann Green, Catherine Williams, Jenny Byrne, Ashish Masurekar, John Harvey, Dave Allen and David Smillie and has published in prestigious journals such as Blood and Transfusion.

In The Last Decade

Gamal Sidra

3 papers receiving 17 citations

Peers

Gamal Sidra
D. W. Kim South Korea
Paul A. Giardina United States
Catarina Maia United States
Kaja Hoyer Denmark
Cody J. Boehner United States
Tamara Westover United States
Sidra Ellis United Kingdom
D. W. Kim South Korea
Gamal Sidra
Citations per year, relative to Gamal Sidra Gamal Sidra (= 1×) peers D. W. Kim

Countries citing papers authored by Gamal Sidra

Since Specialization
Citations

This map shows the geographic impact of Gamal Sidra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gamal Sidra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gamal Sidra more than expected).

Fields of papers citing papers by Gamal Sidra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gamal Sidra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gamal Sidra. The network helps show where Gamal Sidra may publish in the future.

Co-authorship network of co-authors of Gamal Sidra

This figure shows the co-authorship network connecting the top 25 collaborators of Gamal Sidra. A scholar is included among the top collaborators of Gamal Sidra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gamal Sidra. Gamal Sidra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Lucas, Geoff, Gamal Sidra, Ann Green, et al.. (2009). Recipient‐derived HPA‐1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation. Transfusion. 50(2). 334–339. 10 indexed citations
2.
Sidra, Gamal, et al.. (2006). Multiple myeloma: Combination chemotherapy with cyclophosphamide, thalidomide and dexamethasone for patients with refractory, newly diagnosed or relapsed myeloma. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026